179 related articles for article (PubMed ID: 32424768)
1. The prognostic role of tissue TLR2 and TLR4 in colorectal cancer.
Beilmann-Lehtonen I; Böckelman C; Mustonen H; Koskensalo S; Hagström J; Haglund C
Virchows Arch; 2020 Nov; 477(5):705-715. PubMed ID: 32424768
[TBL] [Abstract][Full Text] [Related]
2. The Relationship between the Tissue Expression of TLR2, TLR4, TLR5, and TLR7 and Systemic Inflammatory Responses in Colorectal Cancer Patients.
Beilmann-Lehtonen I; Hagström J; Kaprio T; Stenman UH; Strigård K; Palmqvist R; Gunnarsson U; Böckelman C; Haglund C
Oncology; 2021; 99(12):790-801. PubMed ID: 34515203
[TBL] [Abstract][Full Text] [Related]
3. TLR2 and TLR4 polymorphisms influence mRNA and protein expression in colorectal cancer.
Proença MA; de Oliveira JG; Cadamuro AC; Succi M; Netinho JG; Goloni-Bertolo EM; Pavarino ÉC; Silva AE
World J Gastroenterol; 2015 Jul; 21(25):7730-41. PubMed ID: 26167073
[TBL] [Abstract][Full Text] [Related]
4. Divergent expression of bacterial wall sensing Toll-like receptors 2 and 4 in colorectal cancer.
Paarnio K; Väyrynen S; Klintrup K; Ohtonen P; Mäkinen MJ; Mäkelä J; Karttunen TJ
World J Gastroenterol; 2017 Jul; 23(26):4831-4838. PubMed ID: 28765705
[TBL] [Abstract][Full Text] [Related]
5. High Tissue TLR5 Expression Predicts Better Outcomes in Colorectal Cancer Patients.
Beilmann-Lehtonen I; Hagström J; Mustonen H; Koskensalo S; Haglund C; Böckelman C
Oncology; 2021; 99(9):589-600. PubMed ID: 34139707
[TBL] [Abstract][Full Text] [Related]
6. Serum TLR2 and TLR4 levels in colorectal cancer and their association with systemic inflammatory markers, tumor characteristics, and disease outcome.
Paarnio K; Tuomisto A; Väyrynen SA; Väyrynen JP; Klintrup K; Ohtonen P; Mäkinen MJ; Mäkelä J; Karttunen TJ
APMIS; 2019 Aug; 127(8):561-569. PubMed ID: 31132191
[TBL] [Abstract][Full Text] [Related]
7. High tissue expression of TLRs combined with high density of tumor infiltrating lymphocytes predicts a better prognosis in colorectal cancer patients.
Beilmann-Lehtonen I; Kasurinen J; Hagström J; Kaprio T; Böckelman C; Haglund C
PLoS One; 2023; 18(1):e0280085. PubMed ID: 36649244
[TBL] [Abstract][Full Text] [Related]
8. Toll-like receptor 2 and Toll-like receptor 4 predict favorable prognosis in local pancreatic cancer.
Lanki MA; Seppänen HE; Mustonen HK; Böckelman C; Juuti AT; Hagström JK; Haglund CH
Tumour Biol; 2018 Sep; 40(9):1010428318801188. PubMed ID: 30246618
[TBL] [Abstract][Full Text] [Related]
9. Clinical significance of circulating tumor cells, including cancer stem-like cells, in peripheral blood for recurrence and prognosis in patients with Dukes' stage B and C colorectal cancer.
Iinuma H; Watanabe T; Mimori K; Adachi M; Hayashi N; Tamura J; Matsuda K; Fukushima R; Okinaga K; Sasako M; Mori M
J Clin Oncol; 2011 Apr; 29(12):1547-55. PubMed ID: 21422427
[TBL] [Abstract][Full Text] [Related]
10. High expression of Toll-like receptor 4/myeloid differentiation factor 88 signals correlates with poor prognosis in colorectal cancer.
Wang EL; Qian ZR; Nakasono M; Tanahashi T; Yoshimoto K; Bando Y; Kudo E; Shimada M; Sano T
Br J Cancer; 2010 Mar; 102(5):908-15. PubMed ID: 20145615
[TBL] [Abstract][Full Text] [Related]
11. The Prognostic Value of Cancer Stem Cell Markers (Notch1, ALDH1, and CD44) in Primary Colorectal Carcinoma.
Mohamed SY; Kaf RM; Ahmed MM; Elwan A; Ashour HR; Ibrahim A
J Gastrointest Cancer; 2019 Dec; 50(4):824-837. PubMed ID: 30136202
[TBL] [Abstract][Full Text] [Related]
12. The role of Toll-like receptor 2 and 4 in gingival tissues of chronic periodontitis subjects with type 2 diabetes.
Promsudthi A; Poomsawat S; Limsricharoen W
J Periodontal Res; 2014 Jun; 49(3):346-54. PubMed ID: 23844856
[TBL] [Abstract][Full Text] [Related]
13. Toll-Like Receptor 4 and Matrix Metalloproteases 11 and 13 as Predictors of Tumor Recurrence and Survival in Stage II Colorectal Cancer.
Eiro N; Carrión JF; Cid S; Andicoechea A; García-Muñiz JL; González LO; Vizoso FJ
Pathol Oncol Res; 2019 Oct; 25(4):1589-1597. PubMed ID: 30710321
[TBL] [Abstract][Full Text] [Related]
14. CYP24A1 is a potential biomarker for the progression and prognosis of human colorectal cancer.
Sun H; Wang C; Hao M; Sun R; Wang Y; Liu T; Cong X; Liu Y
Hum Pathol; 2016 Apr; 50():101-8. PubMed ID: 26997443
[TBL] [Abstract][Full Text] [Related]
15. Pathophysiology of reflux oesophagitis: role of Toll-like receptors 2 and 4 and Farnesoid X receptor.
Nortunen M; Väkiparta N; Porvari K; Saarnio J; Karttunen TJ; Huhta H
Virchows Arch; 2021 Aug; 479(2):285-293. PubMed ID: 33686512
[TBL] [Abstract][Full Text] [Related]
16. Intrarenal Toll-like receptor 4 and Toll-like receptor 2 expression correlates with injury in antineutrophil cytoplasmic antibody-associated vasculitis.
O'Sullivan KM; Ford SL; Longano A; Kitching AR; Holdsworth SR
Am J Physiol Renal Physiol; 2018 Nov; 315(5):F1283-F1294. PubMed ID: 29923769
[TBL] [Abstract][Full Text] [Related]
17. High expression of COUP-TF II cooperated with negative Smad4 expression predicts poor prognosis in patients with colorectal cancer.
Wang C; Zhou Y; Ruan R; Zheng M; Han W; Liao L
Int J Clin Exp Pathol; 2015; 8(6):7112-21. PubMed ID: 26261604
[TBL] [Abstract][Full Text] [Related]
18. Clinicopathologic and prognostic significance of immunohistochemical expression of HIF-1α, CXCR4 and CA9 in colorectal carcinoma.
Saka B; Ekinci O; Dursun A; Akyurek N
Pathol Res Pract; 2017 Jul; 213(7):783-792. PubMed ID: 28554753
[TBL] [Abstract][Full Text] [Related]
19. Toll-like receptor-4 expression by stromal fibroblasts is associated with poor prognosis in colorectal cancer.
Eiró N; González L; González LO; Fernandez-Garcia B; Andicoechea A; Barbón E; García-Muñiz JL; Vizoso FJ
J Immunother; 2013; 36(6):342-9. PubMed ID: 23799413
[TBL] [Abstract][Full Text] [Related]
20. Keratin 20 - a diagnostic and prognostic marker in colorectal cancer?
Harbaum L; Pollheimer MJ; Kornprat P; Lindtner RA; Schlemmer A; Rehak P; Langner C
Histol Histopathol; 2012 Mar; 27(3):347-56. PubMed ID: 22237712
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
